Piv study of mixing characteristics in a stirred vessel with a non-Newtonian fluid

PIV is used to analyze the flow induced by a Rushton turbine in a shear-thinning fluid, at constant input power, constant impeller velocity but different concentrations. The rheology of each shear-thinning fluid is first addressed. The mean velocity fields are compared. POD methodology is applied to estimate coherent structures and turbulence levels. Finally, the heterogeneity of shear rate is estimated and the spatial distribution of dissipation rate of total kinetic energy is addressed

Biomechanical breast modelling to improve patient positioning during breast cancer radiotherapy.

International audienceThis paper introduces a 3D FInite Element model of the breast designed to improve patient positioning during breast cancer radiotherapy. The model is used here for the design of a realistic breast phantom developed to quantify the positioning accuracy during radiotherapy

On POD analysis of PIV measurements applied to mixing in a stirred vessel with a shear thinning fluid

P.O.D. technique is applied to 2D P.I.V. data in the field of hydrodynamics in a mixing tank with a Rushton turbine and a shear thinning fluid. Classical eigen-value spectrum is presented and phase portrait of P.O.D. coefficients are plotted and analyzed in terms of trailing vortices. A spectrum of dissipation rate of kinetic energy is introduced and discussed. Length scales associated to each P.O.D. modes are proposed

Analyse locale et globale de l'hydrodynamique et du transfert de matière dans des fluides à rhéologie complexe caractéristiques des milieux de fermentation

La production d éthanol à partir de biomasse lignocellulosique est reconnue comme une des voies possibles de réduction des émissions de gaz à effet de serre et de remplacement partiel des énergies fossiles. Pour être compétitif, la production d'enzymes à bas coûts est nécessaire. Ces enzymes sont produites par le champignon filamenteux Trichoderma reesei, qui présente, à forte concentration, un comportement fortement rhéofluidifiant pouvant entrainer des limitations de mélange et de transfert de matière lors du changement d'échelle. Dans ce travail, il est proposé de compléter les données de la littérature concernant le temps de mélange, la puissance dissipée et le transfert de matière gaz-liquide (global et local) par des mesures à plusieurs échelles dans des fluides modèles de rhéologie similaire aux milieux biologiques visés. Les modèles et corrélations développés qui en résultent sont directement exploitables pour le design des fermenteurs industriels. Afin d étudier plus en détail le mélange, le taux de cisaillement et la turbulence, une étude par PIV a été menée sur des milieux transparents. La caractérisation fine de l'hydrodynamique repose sur la dissociation des différentes composantes du mouvement à l aide de la POD. L'évolution des grandeurs mesurées avec les conditions opératoires permet de fournir des indications précieuses pour l'extrapolation des fermenteurs mettant en œuvre des micro-organismes potentiellement sensibles au cisaillementEthanol made from cellulosic biomass is recognized as a promising substitute for fossil fuel and thus as a way to reduce greenhouse gas emissions. To be competitive, low cost cellulosic enzymes produced by the filamentous fungus Trichoderma reesei are required. At high biomass concentration, the culture broth becomes so highly shear-thinning that mixing and mass transfer limitations may be encountered when the process is scaled up.In this study, we propose to complete data available in the literature for mixing times, power draw, and mass transfer (local and global) with measurements at several scales in model fluids (shear thinning) that mimic the rheology of biological media. Models and correlations that derive from this work can be used directly for industrial fermentor design. In order to study mixing, local shear rate and turbulence in detail, PIV is performed in transparent model fluids. The refined hydrodynamic characterisation relies on the dissociation of instantaneous velocity by means of the POD method. The change of key parameters with operating conditions gives relevant information for the scale-up of shear-sensitive micro-organisms.TOULOUSE-INSA-Bib. electronique (315559905) / SudocSudocFranceF

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer\u27s disease and PET amyloid-positive patient identification

BACKGROUND: Cerebrospinal fluid biomarker profiles characterized by decreased amyloid-beta peptide levels and increased total and phosphorylated tau levels at threonine 181 (pT181) are currently used to discriminate between Alzheimer\u27s disease and other neurodegenerative diseases. However, these changes are not entirely specific to Alzheimer\u27s disease, and it is noteworthy that other phosphorylated isoforms of tau, possibly more specific for the disease process, have been described in the brain parenchyma of patients. The precise detection of these isoforms in biological fluids remains however a challenge. METHODS: In the present study, we used the latest quantitative mass spectrometry approach, which achieves a sensitive detection in cerebrospinal fluid biomarker of two phosphorylated tau isoforms, pT181 and pT217, and first analyzed a cohort of probable Alzheimer\u27s disease patients and patients with other neurological disorders, including tauopathies, and a set of cognitively normal controls. We then checked the validity of our results on a second cohort comprising cognitively normal individuals and patients with mild cognitive impairments and AD stratified in terms of their amyloid status based on PiB-PET imaging methods. RESULTS: In the first cohort, pT217 but not pT181 differentiated between Alzheimer\u27s disease patients and those with other neurodegenerative diseases and control subjects much more specificity and sensitivity than pT181. T217 phosphorylation was increased by 6.0-fold in patients with Alzheimer\u27s disease whereas T181 phosphorylation was only increased by 1.3-fold, when compared with control subjects. These results were confirmed in the case of a second cohort, in which the pT217 cerebrospinal fluid levels marked out amyloid-positive patients with a sensitivity and a specificity of more than 90% (AUC 0.961; CI 0.874 to 0.995). The pT217 concentrations were also highly correlated with the PiB-PET values (correlation coefficient 0.72; P \u3c 0.001). CONCLUSIONS: Increased cerebrospinal fluid pT217 levels, more than those of pT181, are highly specific biomarkers for detecting both the preclinical and advanced forms of Alzheimer\u27s disease. This finding should greatly improve the diagnosis of Alzheimer\u27s disease, along with the correlations found to exist between pT217 levels and PiB-PET data. It also suggests that pT217 is a promising potential target for therapeutic applications and that a link exists between amyloid and tau pathology

Quantitative evaluation of the impact of heterogeneity correction on left breast cancer radiotherapy performed with respiratory gating

Purpose: Our objective was to assess the impact of a heterogeneity correction to the calculated dose for left breast cancer gated radiotherapy.Methods: Ten patients with left breast cancer were studied. For each patient 2 treatment plans were generated. In plan 1 the dose was calculated using a Pencil Beam Convolution (PBC) algorithm. In plan 2 the dose was calculated using the Modified Batho's (MB) density correction method. To compare the two plans a dosimetric analysis was carried out including monitor units (MU), isodose curves, cumulative and differential dose volume histograms (cDVH, dDVH), coverage index, conformity index for target volume and the two dimensional (2D) gamma index (γ). Wilcoxon signed rank and Spearmen's tests were used to calculate p-values and correlation coefficients (r), respectively.Results: MB method reduced the MU by on average 1.12 ± 5.33%. The analysis of cDVH showed that the MB method calculated significantly higher doses for target volumes, lung and heart, p < 0.05. The data demonstrated a strong correlation between the dosimetric parameters derived from plan 1 and plan 2 with r > 0.9. The 2D γ analysis showed that the difference between plan 1 and plan 2 could reach ± 10%. The γ evaluation showed a high impact of density correction for left breast cancer with gating technique.Conclusion: This study confirms that using the MB method integrated with a PBC algorithm, the calculated dose will be increased to target volumes, lung and heart. Even more so since gating usually tends to decrease average lung density by about 39% by treating during an arrested inspiration phase. Thus, attention should be paid when changing from PBC to newer algorithms with gating techniques, since the probability of cardiac mortality and lung toxicity are correlated to absorbed dose

Association of Long-Term Diet Quality with Hippocampal Volume : Longitudinal Cohort Study

BACKGROUND: Diet quality is associated with brain aging outcomes. However, few studies have explored in humans the brain structures potentially affected by long-term diet quality. We examined whether cumulative average of the Alternative Healthy Eating Index 2010 (AHEI-2010) score during adult life (an 11-year exposure period) is associated with hippocampal volume. METHODS: Analyses were based on data from 459 participants of the Whitehall II imaging sub-study (mean age [standard deviation] (SD) = 59.6 [5.3] years in 2002-2004, 19.2% women). Multimodal magnetic resonance imaging examination was performed at the end of follow-up (2015-2016). Structural images were acquired using a high-resolution 3-dimensional T1-weighted sequence and processed with Functional Magnetic Resonance Imaging of the Brain Software Library (FSL) tools. An automated model-based segmentation and registration tool was applied to extract hippocampal volumes. RESULTS: Higher AHEI-2010 cumulative average score (reflecting long-term healthy diet quality) was associated with a larger total hippocampal volume. For each 1 SD (SD = 8.7 points) increment in AHEI-2010 score, an increase of 92.5 mm(3) (standard error = 42.0 mm(3)) in total hippocampal volume was observed. This association was independent of sociodemographic factors, smoking habits, physical activity, cardiometabolic health factors, cognitive impairment, and depressive symptoms, and was more pronounced in the left hippocampus than in the right hippocampus. Of the AHEI-2010 components, no or light alcohol consumption was independently associated with larger hippocampal volume. CONCLUSIONS: Higher long-term AHEI-2010 scores were associated with larger hippocampal volume. Accounting for the importance of hippocampal structures in several neuropsychiatric diseases, our findings reaffirm the need to consider adherence to healthy dietary recommendation in multi-interventional programs to promote healthy brain aging. (C) 2018 The Authors. Published by Elsevier Inc.Peer reviewe

Author Correction:Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates (Scientific Reports DOI: 10.1038/s41598-017-01678-4)

2 p.- Correction to: Scientific Reports https://doi.org/10.1038/s41598-017-01678-4, published online 10 May 2017Peer reviewe

Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles

Blood biomarkers represent a major advance for improving the management, diagnosis, and monitoring of Alzheimer's disease (AD). However, their context of use in relation to routine cerebrospinal fluid (CSF) analysis for the quantification of amyloid peptides and tau proteins remains to be determined. We studied in two independent cohorts, the performance of blood biomarkers in detecting "nonpathological" (A−/T−/N−), amyloid (A+) or neurodegenerative (T+ /N+) CSF profiles. Plasma Aβ/Aβ ratio and phosphorylated tau (p-tau(181)) were independent and complementary predictors of the different CSF profile and in particular of the nonpathological (A−/T−/N−) profile with a sensitivity and specificity close to 85%. These performances and the corresponding biomarker thresholds were significantly different from those related to AD detection. The use of blood biomarkers to identify patients who may benefit from secondary CSF testing represents an attractive stratification strategy in the clinical management of patients visiting memory clinics. This could reduce the need for lumbar puncture and foreshadow the use of blood testing on larger populations. The online version contains supplementary material available at 10.1007/s00702-022-02474-9

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology

OBJECTIVE: Tau hyperphosphorylation at threonine 217 (pT217) in cerebrospinal fluid (CSF) has recently been linked to early amyloidosis and could serve as a highly sensitive biomarker for Alzheimer\u27s disease (AD). However, it remains unclear whether other tauopathies induce pT217 modifications. To determine if pT217 modification is specific to AD, CSF pT217 was measured in AD and other tauopathies. METHODS: Using immunoprecipitation and mass spectrometry methods, we compared CSF T217 phosphorylation occupancy (pT217/T217) and amyloid-beta (Aβ) 42/40 ratio in cognitively normal individuals and those with symptomatic AD, progressive supranuclear palsy, corticobasal syndrome, and sporadic and familial frontotemporal dementia. RESULTS: Individuals with AD had high CSF pT217/T217 and low Aβ42/40. In contrast, cognitively normal individuals and the majority of those with 4R tauopathies had low CSF pT217/T217 and normal Aβ 42/40. We identified a subgroup of individuals with increased CSF pT217/T217 and normal Aβ 42/40 ratio, most of whom were MAPT R406W mutation carriers. Diagnostic accuracies of CSF Aβ 42/40 and CSF pT217/T217, alone and in combination were compared. We show that CSF pT217/T217 × CSF Aβ 42/40 is a sensitive composite biomarker that can separate MAPT R406W carriers from cognitively normal individuals and those with other tauopathies. INTERPRETATION: MAPT R406W is a tau mutation that leads to 3R+4R tauopathy similar to AD, but without amyloid neuropathology. These findings suggest that change in CSF pT217/T217 ratio is not specific to AD and might reflect common downstream tau pathophysiology common to 3R+4R tauopathies